Status:
TERMINATED
A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema
Lead Sponsor:
Aeris Therapeutics
Conditions:
Chronic Pulmonary Obstructive Disease
Emphysema
Eligibility:
All Genders
40+ years
Brief Summary
The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced emphysem...
Detailed Description
The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced homogene...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Confirmation of completion of Aeris' post market follow-up Continuation Study, 03-C10-001PLV.
Exclusion
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2013
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01449175
Start Date
January 1 2011
End Date
November 1 2013
Last Update
November 14 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Otto Wagner Spital Wien
Wein, Austria, A-1140
2
Service de Pneumologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice
Nice, France, 06002 Cedex 1
3
Zentralklinik Bad Berka GmbH
Bad Berka, Germany, D-99437
4
Thoraxklinik Heidelberg
Heidelberg, Germany, D-69126